Essex Property Trust, Inc. vs Revolution Medicines Inc. Common Stock — how do they compare? Essex Property Trust, Inc. trades at $272.94 (market cap $17.26B), while Revolution Medicines Inc. Common Stock trades at $190.87 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 2.3× Essex Property Trust, Inc.'s market cap, and Essex Property Trust, Inc. pays a 3.86% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Essex Property Trust, Inc. for 111 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| ESS | RVMD | |
|---|---|---|
Market Cap | $17.26B | $40.32B |
Volume | 454,464 | 4,855,734 |
Sector | Real Estate | Health |
52-Week High | $298.33 | $221.15 |
52-Week Low | $239.61 | $47.50 |
Typical Hold Time | 111 Days | 0 Days |
Enterprise Value | $23.86B | $37.02B |
Dividend Yield | 3.86% | — |
Signals from Pluang's Aura AI — not financial advice
ESS trades at $273.21, up 1.93% today, but technical indicators signal a bearish trend with resistance near $273. The company reported mixed quarterly earnings, beating in Q1 but missing in Q2 and Q4 2025, while maintaining strong profitability with a net margin of 21.48%. Recent news highlights strong Q2 2026 results and the resolution of litigation, improving the risk profile.
The outlook is cautiously optimistic with a consensus price target of $303.41, implying upside, but risks include earnings volatility and high debt levels. Investor sentiment is mixed, with analysts predominantly holding a neutral stance amid ongoing operational execution challenges in the real estate sector.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Essex Property Trust owns a portfolio of 253 apartment communities with over 62,000 units and is developing three additional properties with 571 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.
Read more on ESS →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →